Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide, Dexamethasone and Ixazomib in Relapsed Multiple Myeloma
NCT02004275Phase 2Unknown
- Sponsor
- Cancer and Leukemia Group B
- Start
- Feb 2014
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixazomib in multiple myeloma (MM), sponsored by Cancer and Leukemia Group B. Status: unknown.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02004275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02004275.